Paul Lytle - Chief Financial Officer at Actuate Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
ACTU on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Paul Lytle since 12/23/2023

Holdings reported by Paul Lytle for Actuate Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Non-Qualified Stock Options 0 Aug 14, 2024 Direct Common Stock

Transactions reported by Paul Lytle for Actuate Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.